Health Care REIT, Inc. (NYSE:HCN) announced operating results for the company’s first quarter ended March 31, 2011. “Health Care REIT remains on target to deliver strong 2011 earnings growth of 8-11%,” commented George L. Chapman, Health Care REIT’s Chairman, Chief Executive Officer and President. “We recently closed the Genesis HealthCare and Benchmark Senior Living transactions on or ahead of schedule. These closings allowed us to recently raise our 2011 FFO guidance by seven cents as these transactions will be immediately accretive to earnings. The $7 billion of new partnerships formed in 2010 and 2011-to-date demonstrates the successful execution of our relationship investment strategy and positions the company for a strong period of earnings and dividend growth over the next several years.”
Health Care REIT, Inc. is an equity real estate investment trust. The firm engages in investment, development, and management of properties. It primarily invests in health care properties.
Power3 Medical Products, Inc (PWRM)
Breast cancer is a malignant tumor that starts from cells of the breast. A malignant tumor is a group of cancer cells that may grow into (invade) surrounding tissues or spread (metastasize) to distant areas of the body. Breast cancer occurs mainly in women, but men can get it, too. Many people do not realize that men have breast tissue and that they can develop breast cancer.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
Breast cancer is always caused by a genetic abnormality (a “mistake” in the genetic material). However, only 5-10% of cancers are due to an abnormality inherited from your mother or father. About 90% of breast cancers are due to genetic abnormalities that happen as a result of the aging process and the “wear and tear” of life in general.
While there are steps every person can take to help the body stay as healthy as possible (such as eating a balanced diet, not smoking, limiting alcohol, and exercising regularly), breast cancer is never anyone’s fault. Feeling guilty, or telling yourself that breast cancer happened because of something you or anyone else did, is not productive.
Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of product NuroPro�, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
BC-SeraPro� is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to the Power3 Medical Products’ patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro� test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.
For more information about Power3 Medical Products, Inc. please visit http://www.power3medical.com
American Video Teleconferencing Corp. (AVOT)
Most people are now familiar with hybrid vehicles, rechargeable batteries, mobile (cell) phones, plasma and LCD screens, laptop computers, disk drives and catalytic converters, but it is not widely known that these products, amongst many others, are dependent on the unique properties of Rare Earth Elements.
American Video Teleconferencing Corp. believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings.
Rare Earth Elements (REE) make the world’s strongest permanent magnets. These magnets are utilized in electric motors to produce greater power and torque, and owing to the power of the magnets, less material is required such that engines can be considerably smaller and lighter in weight. Electric motors that utilize REEs are a key component of hybrid vehicles, which will become increasingly abundant on roads throughout the world in years to come. The powerful REE (Rare Earth Elements) magnets also permit the miniaturization of hard disk drives used in many electrical devices. Neodymium and dysprosium are the REEs with unique magnetic properties.
American Video Teleconferencing Corp. is normally known for its business and efforts of exploration in Rare Earth Elements. According to the Company, it aggressively continues to search world-wide for opportunities in Precious, Base and Rare Earths metal projects in its future strategies.
American Video Teleconferencing Corp. announced that Wayne Lockhart, BSc. Geology, has joined the company as special geological advisor to AVOT for advancing the company’s exploration programs on its newly acquired rare earth property in Quebec. Mr. Lockhart has over 35 years experience in the mining business having worked for Falconbridge and Phelps Dodge in eastern Canada, Anglo American Corp. (DeBeers) in Africa and Benguet Cons. in the Philippines.
Mr. Lockhart in addition to being a lecturer at the University of New Brunswick in Geology has developed programs for the United Nations (UNDP). Mr. Lockhart is an Honorary Director of the Prospector and Developers Association of Canada (PDAC), a founding and former member of the Association of Exploration Geochemists and a Member of the Society of Economic Geologists.
Abbott (NYSE:ABT) will present at the Bank of America Merrill Lynch 2011 Health Care Conference on Thursday, May 12, 2011. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a formal presentation on the company at 10:30 a.m. Central time. A live audio webcast of the presentation will be accessible through Abbott’s Investor Relations Web site at www.abbottinvestor.com.
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide.
CH Energy Group, Inc. (NYSE:CHG) reported first-quarter earnings of $1.08 per share, 22 cents per share lower than the same period of the prior year, when earnings totaled $1.30 per share. “Higher expenses associated with restoration of electric and natural gas service during an unusually harsh winter, accelerated tree trimming, and a partial disallowance of deferred costs from a prior period had significant impacts on our first-quarter results. Normalized for those unique items, first-quarter earnings per share would have totaled $1.31, an increase of 1 cent per share as compared to the first three months of 2010,” said Chairman of the Board, President and C.E.O. Steven V. Lant.
CH Energy Group, Inc., through its subsidiaries, Central Hudson Gas & Electric Corporation (Central Hudson) and Central Hudson Enterprises Corporation (CHEC) engage in the electric utility, natural gas utility, and fuel distribution business.
No comments:
Post a Comment